Binimetinib is a type of inhibitor that works on MEK in melanoma with the BRAF V600E/K mutation, often taken with encorafenib. It stops MEK signaling in its tracks.
It comes in the form of 15 mg film-coated tablets, with a recommended dose of 45 mg taken twice daily. Each bottle holds 84 of these tablets.
Reviews
There are no reviews yet.